C000098971 Performance — Health Sciences Portfolio, Class P
Data updated: 2026-08-11
C000098971 returned +4.42% year to date and +22.70% over one year to Jun 2026. Annualised returns are +8.90% over 3 years and +5.34% over 5 years. The fund trailed its Health Care Equity category average: $100 invested three years ago grew to $129, against $138 for the category, and to $123 over one year, against $137. Volatility over the past three years was 13.31% a year. In the 12 months to Jun 2026 the fund lost a net $49.0M, and assets reached $381.44M.
C000098971 Growth of $100
What $100 invested in Health Sciences Portfolio grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Health Care Equity category average over the same months.
| Period | C000098971 | Category average |
|---|---|---|
| 1 year (Jul 2025 – Jun 2026) | $123 | $137 |
| 3 years (Jul 2023 – Jun 2026) | $129 | $138 |
| 5 years (Jul 2021 – Jun 2026) | $130 | $121 |
| Since data start (Jul 2019 – Jun 2026) | $188 | $182 |
C000098971 Trailing Returns
Total returns to Jun 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +4.42% |
| 1 year | +22.70% |
| 3 years (annualised) | +8.90% |
| 5 years (annualised) | +5.34% |
C000098971 Annual Returns
Calendar-year total returns of Health Sciences Portfolio, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jun) | +4.42% |
| 2025 | +16.52% |
| 2024 | +4.25% |
| 2023 | +3.63% |
| 2022 | −5.62% |
| 2021 | +12.61% |
| 2020 | +19.04% |
| 2019 (Jul–Dec) | +13.29% |
C000098971 Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0.1% | +2.3% | −6.9% | −0.5% | +2.7% | +7.1% | — | — | — | — | — | — |
| 2025 | +7.0% | +0.4% | −3.5% | −2.1% | −4.5% | +2.3% | −1.6% | +4.9% | +1.8% | +4.7% | +9.1% | −2.0% |
| 2024 | +3.3% | +3.0% | +2.0% | −4.2% | +2.8% | +2.5% | +1.8% | +4.2% | −1.8% | −4.1% | +1.5% | −6.1% |
| 2023 | −0.9% | −4.4% | +3.0% | +3.4% | −3.2% | +4.2% | −0.2% | −0.4% | −3.1% | −3.3% | +4.8% | +4.3% |
| 2022 | −8.5% | −0.9% | +4.2% | −4.9% | +0.5% | −1.8% | +3.1% | −5.2% | −3.1% | +9.1% | +4.8% | −1.9% |
| 2021 | +0.2% | −2.0% | +2.2% | +4.5% | +0.1% | +2.6% | +2.2% | +1.1% | −5.3% | +4.0% | −4.2% | +7.3% |
| 2020 | −2.1% | −5.2% | −4.8% | +12.8% | +5.5% | −1.3% | +4.6% | +2.4% | −0.9% | −4.0% | +7.3% | +4.9% |
| 2019 | — | — | — | — | — | — | +0.7% | −0.2% | −2.2% | +5.6% | +5.5% | +3.4% |
C000098971 Risk
Risk measures from monthly returns over Jul 2023 – Jun 2026.
- 3-year volatility (annualised): 13.31%
- 3-year Sharpe ratio: 0.33 (vs 4.5% risk-free rate)
- Best month: +9.13% (Nov 2025)
- Worst month: −6.86% (Mar 2026)
C000098971 Fund Flows
Monthly money in and out of Health Sciences Portfolio, from SEC Form N-PORT.
- 12-month net flow: −$49.0M
- 12-month gross sales (incl. reinvestments): $14.0M
- Sales ÷ redemptions: 0.22×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jun 2026 | $1.5M | $2.7M | −$1.2M |
| May 2026 | $989K | $3.8M | −$2.9M |
| Apr 2026 | $764K | $4.8M | −$4.0M |
| Mar 2026 | $462K | $4.3M | −$3.9M |
| Feb 2026 | $530K | $7.5M | −$7.0M |
| Jan 2026 | $3.2M | $11.9M | −$8.7M |
| Dec 2025 | $1.0M | $7.5M | −$6.4M |
| Nov 2025 | $1.3M | $5.0M | −$3.7M |
| Oct 2025 | $780K | $5.2M | −$4.4M |
| Sep 2025 | $711K | $5.3M | −$4.6M |
| Aug 2025 | $788K | $1.9M | −$1.1M |
| Jul 2025 | $1.9M | $3.0M | −$1.0M |
C000098971 Assets Under Management
Net assets of Health Sciences Portfolio by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-06-30 | $381.44M |
| 2026-03-31 | $356.79M |
| 2025-12-31 | $393.54M |
| 2025-09-30 | $365.17M |
| 2025-06-30 | $354.62M |
| 2025-03-31 | $378.53M |
| 2024-12-31 | $373.37M |
| 2024-09-30 | $418.56M |
| 2024-06-30 | $415.99M |
| 2024-03-31 | $425.22M |
| 2023-12-31 | $400.68M |
| 2023-09-30 | $385.09M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.